Relapse prevention in schizophrenia: attitudes of neurologists-psychiatrists

Citation
Jd. Bergiannaki et al., Relapse prevention in schizophrenia: attitudes of neurologists-psychiatrists, EUR PSYCHIA, 16(2), 2001, pp. 90-98
Citations number
57
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Psychiatry,"Clinical Psycology & Psychiatry
Journal title
EUROPEAN PSYCHIATRY
ISSN journal
0924-9338 → ACNP
Volume
16
Issue
2
Year of publication
2001
Pages
90 - 98
Database
ISI
SICI code
0924-9338(200103)16:2<90:RPISAO>2.0.ZU;2-L
Abstract
The overall high relapse rates observed in schizophrenia are attributed to several causes. One important factor influencing satisfactory prevention of relapse is the lack of consistent treatment strategies among medical docto rs, especially neurologists-psychiatrists. Nearly one-third of the members of the Hellenic Society of Neurology and Psychiatry were asked to fill in a nonymously a structured questionnaire on their treatment attitudes and pres cribing tactics regarding schizophrenic patients both after the first schiz ophrenic episode and after multiple episodes. The majority of Greek neurolo gists-psychiatrists seem to adopt prescribing habits that approximate the c urrent international standards for prevention of schizophrenic relapse. The ir attitudes regarding the treatment and prevention of relapse for the firs t schizophrenic episode and first relapse are determined from multiple fact ors. These are: the expected relapse rates after the first episode, the exp ected prevalence of extrapyramidal side effects following a long-term neuro leptic treatment, the patient's expected treatment compliance after the fir st episode, the doctor's experience with treating schizophrenics, and lastl y the knowledge of current literature on the topic. These results point to the need for continuing education, especially of the younger mental health professionals and those working in the private sector, addressing the issue of the actual risk of developing side effects from the treatment. In due c ourse, benefits could result for everyday psychiatric practice and the pati ents' compliance with treatment. (C) 2001 Editions scientifiques et medical es Elsevier SAS.